NASDAQ: ISPC
Ispecimen Inc Stock Ownership - Who owns Ispecimen?

Insider buying vs selling

Have Ispecimen Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when ISPC insiders and whales buy or sell their stock.

ISPC Shareholders

What type of owners hold Ispecimen Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Andrew L. Ross156.89%3,951,388$5.26MInsider
George H. Scholl33.55%845,106$1.12MInsider
Obf Investments LLC33.43%841,981$1.12MInsider
Christopher Ianelli16.89%425,359$565.73kInsider
Jill Mullan9.78%246,226$327.48kInsider
Benjamin Bielak3.35%84,348$112.18kInsider
Tracy Curley1.97%49,541$65.89kInsider
John L. Brooks Iii0.13%3,250$4.32kInsider
Steven R. Phd Gullans0.13%3,250$4.32kInsider
John L. Brooks0.12%3,125$4.16kInsider

1 of 3

ISPC vs Diagnostic & Research Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ISPC0.00%100.00%
MDXH0.03%83.20%Net BuyingNet Buying
VNRX0.00%100.00%Net Buying
TRIB0.01%3.98%
BIAF0.02%99.98%

Ispecimen Stock Ownership FAQ

Who owns Ispecimen?

Ispecimen (NASDAQ: ISPC) is owned by 0.00% institutional shareholders, 256.36% Ispecimen insiders, and 0.00% retail investors. Andrew L. Ross is the largest individual Ispecimen shareholder, owning 3.95M shares representing 156.89% of the company. Andrew L. Ross's Ispecimen shares are currently valued at $5.26M.

If you're new to stock investing, here's how to buy Ispecimen stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.